Global Breast Augmentation Market - 2024-2031

Overview

The global breast augmentation market reached US$ 1,289.6 million in 2023 and is expected to reach US$ 3,440.6 million by 2031, growing at a CAGR of 13.0% during the forecast period 2024-2031.

Breast augmentation, also referred to as augmentation mammoplasty, is a surgical procedure designed to enhance the size and volume of the breasts. This enhancement can be accomplished using breast implants or through fat transfer techniques. Individuals often seek this procedure for a variety of reasons, such as increasing breast fullness, restoring volume lost due to weight loss or pregnancy, correcting asymmetry between the breasts, and improving overall body proportions.

The choice of implant type and placement method can significantly influence the aesthetic outcome and recovery experience. Patients often pursue this procedure to boost self-confidence and improve their body image. While breast augmentation can enhance appearance.

Breast augmentations are ranked as the number one cosmetic surgery for women based on gender distribution data, while breast implants are ranked as the 13th most popular procedure among men.

Market Dynamics: Drivers & Restraints

Growing demand for cosmetic procedures

The growing demand for cosmetic procedures, influenced by a blend of social, cultural, economic, and technological elements, is a key factor driving the expansion of the breast augmentation market. The market is witnessing substantial growth as more individuals pursue aesthetic enhancements such as breast augmentation.

Many people seek breast augmentation not only for cosmetic reasons but also to improve their self-esteem and body image. This procedure can empower women, helping them feel more confident and at ease in their own bodies. The number of individuals undergoing breast augmentation is expected to rise with the growing interest among individuals. For instance, according to the report by the American Society of Plastic Surgeons in 2023, breast augmentation, including both primary and revision implant placements, accounted for 304,181 procedures. In 2022, 298,568 breast augmentation procedures were performed. There was almost a 2% increase in the total breast augmentation procedures from 2022-2023.

The age group between 30-39, is at the forefront of breast augmentation procedures. In 2023, this group accounted for 38 percent of all breast augmentations, driven by a mix of aesthetic aspirations and a growing acceptance of cosmetic enhancements. Additionally, there has been an increase in the number of women pursuing reconstructive surgery after breast cancer treatment. In these cases, breast implants are frequently utilized, offering a solution for breast reconstruction and assisting patients in regaining a sense of normalcy. The rise in breast cancer survivors seeking reconstruction has further contributed to the demand for breast implants, broadening the market to encompass both cosmetic enhancements and medical reconstructive needs.

Moreover, the increasing advancements in surgeries and the approvals of more breast implants with advanced features are expected to drive the breast augmentation market.

Complications and side effects associated with breast augmentation

Complications and side effects linked to breast augmentation procedures are expected to considerably impede the growth of the breast augmentation market. The complications and side effects such as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) or other very rare cancers in the capsule around the breast, such as breast implant-associated squamous cell carcinoma (BIA-SCC) could result after breast augmentation.

Also bleeding, changes in breast sensation, fluid accumulation (seroma), formation of tight scar tissue around the implant (capsular contracture), hematoma, implant leakage or rupture, infection, persistent pain, and poor scarring complications associated with breast augmentation are expected to restrict the individual from undergoing the breast augmentation procedure. There is a large increase in the number of individuals who have removed breast implants which could be due its side effects.

Segment Analysis

The global breast augmentation market is segmented based on augmentation type, shape, surface type, application, end-user, and region.

Augmentation Type:

The breast implants segment is expected to dominate the global breast augmentation market share

The breast implants segment is experiencing significant growth, driven by several key factors. Patients are increasingly opting for silicone implants due to their more natural appearance and feel compared to saline alternatives. This growing preference for silicone implants is fueling the demand within the market. Additionally, the rising incidence of breast cancer has further contributed to the growth of this segment, as breast implants are commonly used for post-mastectomy reconstruction.

The segment's expansion is also supported by ongoing product approvals, frequent new product launches, and continuous innovations in implant technology. Companies are addressing the growing patient demand for longer-lasting implants by improving durability and reducing the risk of complications such as rupture and leakage. Advancements in cohesive silicone gels and enhanced outer shell designs have resulted in implants that can last longer, with some products offering warranties of 10 years or more.

With the rising demand for breast implants, the companies are introducing their products. For instance, in April 2024 GC Aesthetics (GCA) introduced a micro-textured anatomical breast implant LUNA XT. The company says it is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).

Furthermore, manufacturers are increasingly focusing on biocompatibility, ensuring that implants are not only safe but also well-tolerated by the body. The development of biocompatible materials helps minimize the risks of inflammation and immune system rejection, enhancing the safety and success of breast implant procedures.

Moreover, the Food and Drug Administration (FDA) is approving breast implants by evaluating their safety. For instance, in September 2024, the FDA approved for marketing of Motiva USA, LLC's SmoothSilk Round and Round Ergonomic Silicone Gel-Filled Breast Implants, indicated for breast augmentation for patients of at least 22 years of age.

Together, these factors are propelling the breast implant segment toward continued growth and dominance in the breast augmentation market. As these trends progress, the segment's growth is expected to expand substantially.

Geographical Analysis

North America is expected to hold a significant position in the global breast augmentation market share

North America holds a dominant position in the breast augmentation market. The region's dominance in the breast augmentation market is attributed to several critical factors that collectively enhance its position. The increasing number of breast augmentation surgeries reflects a growing societal acceptance of cosmetic enhancements. For instance, according to the publication by the Toronto Plastic Surgeons, in the United States alone, 255,200 breast augmentation surgeries were performed in 2022, making it the leader in this category globally with approximately 11.7% of the total number of breast augmentations performed worldwide.

Technological advancements play a pivotal role in this market's growth. Innovations such as cohesive silicone gel implants have significantly improved safety and aesthetic outcomes, enhancing patient satisfaction and driving further demand for breast augmentation procedures.

The region's robust regulatory environment ensures high safety standards for medical devices and procedures, fostering consumer confidence in breast augmentation options. With the rising approvals of breast implants in the region, the region is addressing the rising demand for breast implants globally. The rising number of approvals of implants is also expected to contribute to the region's market growth. For instance, in March 2022, Sientra, Inc. received approval from Health Canada to market the Company's line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in Canada.

As these factors continue to evolve, North America is expected to maintain its dominant position in the breast augmentation market, contributing to a thriving landscape that is projected to grow in the coming years.

Asia Pacific is growing at the fastest pace in the global breast augmentation market

The Asia-Pacific (APAC) region is currently emerging as one of the fastest-growing markets for breast augmentation, encompassing both aesthetic and reconstructive procedures. Several factors contribute to the rapid expansion of the breast augmentation market in this region. There is a growing societal focus on physical appearance and body image in the APAC region, resulting in heightened acceptance of cosmetic procedures among women. This cultural shift is driving an increased demand for aesthetic enhancements, including breast augmentation.

Competitive Landscape

The major global players in the breast augmentation market include Johnson & Johnson, AbbVie, Sientra, Inc., GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sebbin, Laboratoires Arion, Silimed, Establishment Labs and Guangzhou Wanhe Plastic Material Co., Ltd among others.

Key Developments

• In September 2024, GC Aesthetics (GCA) launched the YOUTHLY brand in China, featuring its latest breast implant innovations: PERLE, Luna XT, and the latest version of The Round Collection, 100% filled.
• In September 2024, POLYTECH introduced Opticon Plus, an innovative addition to its broad portfolio. POLYTECH's portfolio now includes this new implant, which sits between their anatomical forms Replicon and Opticon, providing surgeons with an option that features a base shape between the round Replicon(R) base and the standard Opticon short oval base.

Why Purchase the Report?

• Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
• Market Positioning: Analysis of product performance and growth potential for optimized strategies.
• Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
• Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
• Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
• Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
• Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
• Market Expansion: Strategies for entering new markets and forming partnerships.
• Regional Opportunities: Identification of high-growth regions and investment prospects.
• Supply Chain Optimization: Assessment of risks and distribution strategies.
• Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
• Post-Market Surveillance: Enhanced safety and access through post-market data.
• Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global breast augmentation market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.